Company intelligence / Profile preview

Southend Pharmacy

Houston, Texas, United States

Ownership: Private
Employees: ~150

Overview

Southend Pharmacy is a Houston-based, state-licensed 503A compounding pharmacy that specializes in patient-specific formulations for metabolic support, weight management, and longevity therapies. Operating from a 55,200-square-foot facility, the pharmacy serves over 10,000 healthcare providers and telehealth platforms across more than 35 states. As a key subsidiary of Allia Health Group, Southend Pharmacy provides customized sterile and non-sterile preparations, including compounded GLP-1 medications like semaglutide and tirzepatide. The company focuses on clinical precision, rigorous compliance, and next-day cold-chain delivery to support modern, personalized patient care.

Modalities: Small moleculePeptidesBiologic
Industry: Non-Academic Healthcare

Partnerships

Brello HealthHelloWellnessMochi HealthFuture Health

Beyond the preview

Go deeper on Southend Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Southend Pharmacy.

Explore the full profile